U.S. Analytical Instrumentation Market Is Set For Lucrative Growth To 2030

U.S. Analytical Instrumentation Market Summary

The U.S. analytical instrumentation market size was valued at USD 24.10 billion in 2024 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2030. Analytical instrumentation encompasses a broad spectrum of laboratory tools designed for the identification, separation, and quantification of chemical components in both natural and synthetic materials.

Within the U.S., these instruments serve as a cornerstone in critical industries such as environmental monitoring, food safety, pharmaceuticals, and biotechnology. Common analytical tools used extensively across U.S. laboratories include mass spectrometers, chromatography systems such as high-performance liquid chromatography (HPLC) and gas chromatography (GC), spectrophotometers, and nuclear magnetic resonance (NMR) spectrometers. These tools are essential for delivering both qualitative and quantitative data regarding the specific content and concentrations of compounds present in various samples.

One of the key factors expected to drive growth in this market is the increasing national interest in precision medicine. Precision medicine focuses on tailoring medical treatment to individual characteristics, particularly a person’s genetic profile. Analytical instruments play a vital role in this approach by facilitating accurate diagnosis and enabling the development of targeted therapies.

For instance, technologies such as genomic sequencing allow clinicians and researchers to identify optimal treatments based on the genetic structure of an individual patient. Furthermore, advanced microscopy techniques, including cryogenic electron microscopy (cryo-EM), are increasingly being utilized in pharmaceutical research to analyze the intricate structure of proteins, which aids in the discovery and design of innovative therapeutics.

Key Market Trends & Insights

• In 2024, the instruments segment accounted for the largest market share at 54.5%. This dominance is largely attributed to the extensive range of analytical tools available from numerous manufacturers, encompassing chromatographs, mass spectrometers, sequencers, and various types of microscopes. Moreover, continuous investment in research and development has led to technological improvements in instrument performance, automation, data integration, and miniaturization. These advancements are further fueling the growth of the analytical instrumentation sector by enhancing accuracy, speed, and ease of use across multiple applications.
• The polymerase chain reaction (PCR) segment captured the highest market share in 2024. This strong performance is driven by the technique’s versatility, rapidity, and precision. PCR allows for the amplification of specific DNA sequences from minimal sample inputs, making it invaluable in a wide range of applications including clinical diagnostics, forensic analysis, genetic identity testing, in vitro diagnostics (IVD), and quality control in various industrial processes. Its efficiency and accuracy continue to make PCR one of the most relied-upon molecular tools in both clinical and research laboratories.
• Looking ahead, the clinical and diagnostics analysis segment is projected to experience the fastest CAGR throughout the forecast period. The segment’s robust growth is primarily linked to the rising prevalence of chronic diseases and increasing incidence of cancer across the United States. These health challenges are intensifying the demand for early and precise diagnostic testing, which in turn is elevating the need for advanced analytical instruments capable of delivering high-sensitivity results and reducing diagnostic turnaround times. The trend toward point-of-care testing and non-invasive diagnostic methods is also contributing to the segment’s momentum.

Order a free sample PDF of the U.S. Analytical Instrumentation Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 24.10 billion
• 2030 Projected Market Size: USD 29.60 billion
• CAGR (2025 - 2030): 3.5%

Key Companies & Market Share Insights

The key companies engage in partnerships, mergers, and acquisitions to strengthen their product portfolio, expand their manufacturing capacities, and provide competitive differentiation.

• Thermo Fisher highlights its advanced analytical instrumentation, such as NIR and Raman spectroscopy, rheometry, FTIR, UV‑Vis, and XRD. These instruments are designed to monitor and optimize drug formulation and manufacturing processes, providing real-time quality control and compliance support.

Key Players

• Thermo Fisher Scientific, Inc.
• Danaher
• Agilent Technologies, Inc.
• Bruker Corp.
• PerkinElmer, Inc.
• Mettler Toledo
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• F. Hoffmann-La Roche AG
• Avantor, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. analytical instrumentation market is expected to witness steady growth, driven by technological advancements, rising healthcare demands, and growing adoption across diverse industries. Precision medicine, increasing chronic disease burdens, and innovations in drug discovery are significantly boosting demand for advanced analytical tools. Instruments like PCR systems and spectrometers continue to be vital for accurate and rapid analysis. The clinical and diagnostics segment is poised for robust expansion, supported by the shift toward personalized healthcare. With a strong foundation in innovation and cross-sector applications, the analytical instrumentation market will remain integral to scientific progress and improved health outcomes in the coming years.